3D Biotek, LLC, a pioneering biotechnology company established in 2007, leads the field in Precision 3D Micro-Fabrication Technology and Advanced Bio-Manufacturing. Based in New Jersey, USA, 3D Biotek focuses on developing innovative 3-dimensional (3D) cell culture devices for stem cell/tissue engineering and drug discovery. Their flagship product, the 3D Insert TM, consists of unique 3D porous scaffolds ideal for drug screening, stem cell research, and tissue engineering applications.

By utilizing these advanced products, researchers can create more realistic in vitro models, ultimately reducing costs and time to market in therapeutic and pharmaceutical development. Additionally, 3D Biotek offers services for custom biomedical device fabrication and is currently working on launching the 3D Cell Expansion System (3D-CES) in 2023. This revolutionary system allows for large-scale stem cell expansion in a dynamic 3D micro-environment, with potential applications in bio-banking, stem cell therapy, and protein production.

A forward-thinking brand committed to innovation and excellence in the biotechnology sector